Original news and analysis on international IP policy
United States Trade Representative Michael Froman and Indian Minister of Commerce and Industry Nirmala Sitharaman met in Delhi today and discussed various bilateral issues including intellectual property rights. Based on the release from the meeting, it appears much of the IP focus was on tasks for India to do to better protect IP rights.
With the vote on the European Union-Canada trade agreement (CETA) on the agenda once more at the upcoming EU Council meeting tomorrow the representatives of European and Canadian cities and regions gathered at Brussels today for a “CETA Citizens' Summit.” Gerardo Pisarello, vice mayor of the city of Barcelona, said that cities like his see CETA as a barrier to their plans to remunicipalize water and energy services and the attempts “to open up public procurement to small companies and cooperatives."
While US Democratic presidential candidate Hillary Clinton has published detailed positions on intellectual property, technology transfer and trade, Republican candidate Donald Trump has limited his comments to trade reform and alleged Chinese IP theft. The policy vacuum has left the IP community not only uncertain of Trump's intentions but unable even to find the right people to ask, one IP attorney said. [Note: story updated with a comment about IP made by Trump]
Intellectual property and competition authorities should collaborate, but other institutions should also have their say, such as health ministries, speakers said at a United Nations meeting of experts this week. And guidelines should be provided to judges in the difficult task of determining whether IP rights monopolies impede on competition, they said. This special report takes a deeper look at IPRs, competition, and differing economies.
The invitation by the South African Department of Trade and Industry (DTI) to intellectual property stakeholders to comment on its recently released IP Consultative Framework has reignited calls for the department to come clean on the status of the national draft IP policy.
Gavi, the vaccine alliance, announced yesterday that a UNICEF pentavalent vaccine tender will secure sufficient supplies for the next three years to protect millions of children in Gavi-supported and transitioning countries.
Bangalore-based Biocon may become the first Indian company to offer a biosimilar insulin in Europe. And the patent and pricing story is interesting.
Fresh from intense discussions at the World Intellectual Property Organization General Assemblies earlier this month, delegates to a WIPO committee today agreed to hold an information session on geographical indications in the spring, and to further work on industrial designs. However, no further discussions to help break the deadlock on a proposed design law treaty could be arranged this week.
Nearly 100 health, community and development organisations working in the Asia-Pacific region issued a call for trade ministers negotiating the Regional Comprehensive Economic Partnership (RCEP) trade agreement to "reject provisions that would negatively affect access to generic medicines." Negotiators are meeting from 17-22 October in China, and the concern is about the intellectual property chapter of the deal.
Pharmaceutical manufacturer Eli Lilly today announced a stepped-up commitment to provide improved access to quality healthcare for 30 million people in resource-limited settings by 2030.
Imagine you’re an inventor in the Philippines and want to file a patent for, say, a fishing implement you’ve invented, but your $9,000 a year income thwarts your ability to pay the legal fees to register it and develop it commercially.
You could be stumped from the start.
Pressure from staff and now from members of the European Patent Office governing body has forced EPO President Benoît Battistelli to withdraw controversial proposals for disciplining and investigating employees, the Staff Union of the EPO (SUEPO) said on 17 October. The action was welcomed but the situation is far from resolved, staff members say.